Cargando…

Managing Cystic Fibrosis related diabetes via telehealth during COVID-19 pandemic

Coronavirus disease 2019 (COVID-19) was declared a pandemic on March 11, 2020. In efforts to reduce the risk of transmission, telehealth visits for routine care has significantly increased in the United States. Cystic fibrosis patients have been categorized as a highly vulnerable population to COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasan, Sana, Cecilia Lansang, M., Salman Khan, Mohammad, Dasenbrook, Elliot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942190/
https://www.ncbi.nlm.nih.gov/pubmed/33723506
http://dx.doi.org/10.1016/j.jcte.2021.100253
Descripción
Sumario:Coronavirus disease 2019 (COVID-19) was declared a pandemic on March 11, 2020. In efforts to reduce the risk of transmission, telehealth visits for routine care has significantly increased in the United States. Cystic fibrosis patients have been categorized as a highly vulnerable population to COVID-19 infection. Cystic Fibrosis centers are rapidly assessing and responding to the pandemic to ensure the safety of CF patients. At our Cleveland Clinic Cystic Fibrosis center, we transitioned outpatient clinics to a virtual care model in March 2020. Here, we report the changes that were implemented to optimize diabetes management in CF patients through telehealth during the COVID-19 crisis.